← FDA DRUG APPROVALS

FDA ANDA · ANDA202583

CROMOLYN SODIUM

Sponsor: RISING

APPLICATION
ANDA202583
TYPE
ANDA
ORIGINAL APPROVAL
2011-10-27
LATEST ACTION
2011-10-27
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Prescription

Products

CROMOLYN SODIUMPrescription
CROMOLYN SODIUM 100MG/5ML · CONCENTRATE · ORAL

Approval history

2011-10-27UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →